Guest guest Posted February 24, 2006 Report Share Posted February 24, 2006 Subscribe now>> <http://main.diabetes.org/site/R?i=h8tdI7yVGx5i46rX4GqndA..> Anti-obesity Pill Reduces Weight, Improves Lipids In a two-year study of overweight or obese subjects, a marijuana derivative, or cannabinoid, called rimonabant (Acomplia) helped those who took it lose weight and improve their cardiovascular risk profile. Weight loss occurred after one year of taking the drug and was sustained over a second year if treatment was continued. The agent also improved cardiometabolic risk factors even more than the amount of weight loss would have predicted. " Our observations collectively suggest that rimonabant may well represent an innovative approach to the management of multiple cardiometabolic risk factors, " the authors write in the Journal of the American Medical Association. Dr. F. Xavier Pi-Sunyer, from St. Luke's-Roosevelt Hospital in New York, and his associates initially randomized 607 subjects to placebo, 1214 to rimonabant 5 mg, and 1219 to rimonabant 20 mg, while advising them to reduce their calorie intake by approximately 600 kcal/day and to increase physical activity. Learn more>> <http://main.diabetes.org/site/R?i=h5y93DXTODFEzwqZJ_-SNQ..> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.